Results 251 to 260 of about 1,742,691 (356)

Absolute scaling of small‐ and wide‐angle X‐ray scattering images recorded with short duration X‐ray pulses on a large area fiber‐taper X‐ray detector

open access: yesJournal of Synchrotron Radiation, Volume 33, Issue 3, Page 562-579, May 2026.
An X‐ray scattering setup designed to capture small‐ and wide‐angle X‐ray scattering on a single, large area detector features a partially transmissive beamstop that facilitates non‐invasive recording of X‐ray beam position and intensity during acquisition of X‐ray scattering images.
Hyun Sun Cho   +3 more
wiley   +1 more source

Production of clinical grade patient iPSC-derived 3D retinal organoids containing transplantable photoreceptor cells. [PDF]

open access: yesStem Cell Res Ther
Bohrer LR   +11 more
europepmc   +1 more source

Japanese Clinical Practice Guidelines for Vascular Tumors, Vascular Malformations, Lymphatic Malformations, and Lymphangiomatosis 2022

open access: yesThe Journal of Dermatology, Volume 53, Issue 5, Page e257-e356, May 2026.
ABSTRACT The objective was to prepare guidelines to perform the current optimum treatment by organizing effective and efficient treatments of hemangiomas and vascular malformations, confirming the safety, and systematizing treatment, employing evidence‐based medicine techniques and aimed at improvement of the outcomes.
Yoshiaki Kinoshita   +116 more
wiley   +1 more source

Ion Crowding Effect in Unilaterally Downsized Perovskite Memristors. [PDF]

open access: yesAdv Sci (Weinh)
Tan C   +11 more
europepmc   +1 more source

Cognitive and Psychomotor Processing Speed in Medication‐Naïve Individuals With First‐Episode of Psychosis: The Role of Peripheral Inflammatory Markers

open access: yesActa Psychiatrica Scandinavica, Volume 153, Issue 5, Page 477-489, May 2026.
ABSTRACT Background and Hypothesis Deficits in processing speed (PS) and psychomotor speed (PMS) are core cognitive impairments in schizophrenia spectrum disorders, including first‐episode psychosis (FEP). Neuroinflammation has been proposed as a potential contributor to these deficits.
Ángel Yorca‐Ruiz   +8 more
wiley   +1 more source

Matsupexole: A novel nonergot dopamine receptor agonist with sustained efficacy in a rat model of Parkinson's disease and limited off‐target activity

open access: yesBritish Journal of Pharmacology, Volume 183, Issue 10, Page 2518-2532, May 2026.
Background and Purpose Dopamine receptor agonists, particularly targeting the dopamine D2L receptor (D2LR), have been used to treat Parkinson's disease (PD). However, valvular heart disease and somnolence, mainly caused by activating the serotonin 5‐HT2B receptor (5‐HT2BR) and dopamine D3 receptor (D3R), respectively, currently challenge their clinical
Takayuki Suzuki   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy